TaofeekKunkleOwonikokoMDPhD(He/Him)

Summary

• Taofeek K. Owonikoko, MD, PhD, is the Executive Director of the University of Maryland’s NCI-designated Marlene and Stewart Greenebaum Comprehensive Cancer Center. He is also the Senior Associate Dean of Cancer Programs at the University of Maryland’s School of Medicine and is the Associate Vice President of Cancer Programs at the University of Maryland, Baltimore.
  
  He is a translational Physician-Scientist, board-certified in Medical Oncology, Hematology, and Internal Medicine with a clinical focus on treating patients with lung cancer. His research interests span the spectrum of preclinical experimental therapeutics, biomarker discovery, and translation of promising laboratory findings into clinical trials. Furthermore, he serves as an elected Board Member and Treasurer-Elect of the American Society of Clinical Oncology (ASCO). He is additionally an Editorial Board Member for several highly regarded academic journals including Cancer, Frontiers in Oncology, Journal of Thoracic Disease, and Translational Lung Cancer Research. Dr. Owonikoko is a member of the American College of Physicians, American Society for Hematology, the Society for Immunotherapy of Cancer, and the International Association for the Study of Lung Cancer, just to name a few. Lastly, he has been an NIH Study Section Member for the past eleven years.
  
  Dr. Owonikoko has authored/co-authored over 250+ peer-reviewed original manuscripts in leading journals including the New England Journal of Medicine, Lancet, Cell, Science, Nature, JCO, Lancet Oncology, Cancer Discovery, and Cancer Cell. His work has been broadly cited with more than 49,000 citations and an h-index of 86. He has received peer-reviewed extramural grant funding in support of his research from the US National Institutes of Health, Department of Defense, private foundations, and pharmaceutical partners.